The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Locus Ceruleus Degeneration Promotes Alzheimer Pathogenesis in Amyloid Precursor Protein 23 Transgenic Mice
Open accessAbstract
Locus ceruleus (LC) degeneration and loss of cortical noradrenergic innervation occur early in Alzheimer’s disease (AD). Although this has been known for several decades, the contribution of LC degeneration to AD pathogenesis remains unclear. We induced LC degeneration with N-(2-chloroethyl)-N-ethyl-bromo-benzylamine (dsp4) in amyloid precursor protein 23 (APP23) transgenic mice with a low amyloid load. Then 6 months later the LC projection areas showed a robust elevation of glial inflammation along with augmented amyloid plaque deposits. Moreover, neurodegeneration and neuronal loss significantly increased. Importantly, the paraventricular thalamus, a nonprojection area, remained unaffected. Radial arm maze and social partner recognition tests revealed increased memory deficits while high-resolution magnetic resonance imaging-guided micro-positron emission tomography demonstrated reduced cerebral glucose metabolism, disturbed neuronal integrity, and attenuated acetylcholinesterase activity. Nontransgenic mice with LC degeneration were devoid of these alterations. Our data demonstrate that the degeneration of LC affects morphology, metabolism, and function of amyloid plaque-containing higher brain regions in APP23 mice. We postulate that LC degeneration substantially contributes to AD development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, lesioning of another projection pathway, that from the locus coeruleus, was reported to increase plaque pathology in terminal fields of the cerebral cortex [72].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Self-citationWidespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,003
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946
Flagged first, then by citations
1 of the 54 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- (1994), Pharmacopsychiatry, 27, 11
Cited by
Sorted by citations
Items 101–200 of 305
Associations among locus coeruleus catecholamines, tau pathology, and memory in aging
Ciampa, C. J., Parent, J. H., Harrison, T. M., Fain, R. M., Betts, M. J., Maass, A., Winer, J. R., Baker, S. L., Janabi, M., Furman, D. J., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01269-6 · Cited by 54
Tau modification by the norepinephrine metabolite DOPEGAL stimulates its pathology and propagation
Kang, S. S., Meng, L., Zhang, X., Wu, Z., Mancieri, A., Xie, B., Liu, X., Weinshenker, D., Peng, J., Zhang, Z., et al. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00745-3 · Cited by 55
Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
Peterson, A. C., & Li, C. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00127 · Cited by 58
The role of Locus Coeruleus in neuroinflammation occurring in Alzheimer’s disease
Giorgi, F. S., Saccaro, L. F., Galgani, A., Busceti, C. L., Biagioni, F., Frati, A., & Fornai, F. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.08.007 · Cited by 53
Multimodal Imaging of Neural Progenitor Cell Fate in Rodents
Waerzeggers, Y., Klein, M., Miletić, H., Himmelreich, U., Li, H., Monfared, P., Herrlinger, U., Hoehn, M., Coenen, H. H., Weller, M., et al. (2008) · Molecular Imaging · doi:10.2310/7290.2008.0010 · Cited by 52
Self-citationFjell, A. M., Idland, A., Sala‐Llonch, R., Watne, L. O., Borza, T., Brækhus, A., Lona, T., Zetterberg, H., Blennow, K., Wyller, T. B., et al. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx157 · Cited by 57
Does sleep disturbance affect the amyloid clearance mechanisms in A lzheimer's disease?
Yuluğ, B., Hanoğlu, L., & Kılıç, E. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12539 · Cited by 53
Yang, J. H., Lee, E. O., Kim, S. E., Suh, Y.-H., & Chong, Y. H. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.05.008 · Cited by 51
Daulatzai, M. A. (2012) · Neurochemical Research · doi:10.1007/s11064-011-0680-2 · Cited by 49
A Noradrenergic Lesion Exacerbates Neurodegeneration in a Down Syndrome Mouse Model
Lockrow, J. P., Boger, H. A., Gerhardt, G. A., Aston‐Jones, G., Bachman, D., & Granholm, A. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101218 · Cited by 49
How reliable is cerebral blood flow to map changes in neuronal activity?
Lecrux, C., Bourourou, M., & Hamel, É. (2019) · Autonomic Neuroscience · doi:10.1016/j.autneu.2019.01.005 · Cited by 54
Kelly, L., Seifi, M., Ma, R., Mitchell, S. J., Rudolph, U., Viola, K. L., Klein, W. L., Lambert, J. J., & Swinny, J. D. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12674 · Cited by 48
Late-in-life neurodegeneration after chronic sleep loss in young adult mice
Owen, J. E., Zhu, Y., Fenik, P., Zhan, G., Bell, P., Liu, X. C., & Veasey, S. C. (2021) · SLEEP · doi:10.1093/sleep/zsab057 · Cited by 51
Mouse models in neurological disorders: Applications of non-invasive imaging
Waerzeggers, Y., Monfared, P., Viel, T., Winkeler, A., & Jacobs, A. H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.04.009 · Cited by 47
Self-citationLi, L., Cheung, T., Chen, J., & Herrup, K. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/171464 · Cited by 48
Ramos‐Rodríguez, J. J., Gil, S. M., Rey-Brea, R., Berrocoso, E., & Garcı́a-Alloza, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079947 · Cited by 47
Quantitative Rodent Brain Receptor Imaging
Herfert, K., Mannheim, J. G., Kuebler, L., Marciano, S., Amend, M., Parl, C., Napieczyńska, H., Maier, F. M., Vega, S. C., & Pichler, B. J. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01368-9 · Cited by 47
Counts, S., & Mufson, E. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374236-0.10012-4 · Cited by 44
Stress and Alzheimer’s disease: A senescence link?
Lyons, C. E., & Bartolomucci, A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.010 · Cited by 49
Slater, C. L., & Wang, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.397 · Cited by 47
Astrocytic energy metabolism consolidates memory in young chicks
Gibbs, M. E., O'Dowd, B. S., Hertz, E., & Hertz, L. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.04.038 · Cited by 46
Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target
Gutiérrez, I. L., Russo, C. D., Novellino, F., Caso, J. R., García‐Bueno, B., Leza, J. C., & Madrigal, J. L. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116143 · Cited by 53
Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer’s disease
Kang, S. S., Ahn, E. H., & Ye, K. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00494-7 · Cited by 46
Scullion, G. A., Kendall, D. A., Marsden, C. A., Sunter, D., & Pardon, M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.002 · Cited by 44
Locus Coeruleus Magnetic Resonance Imaging in Neurological Diseases
Galgani, A., Lombardo, F. P., Latta, D. D., Martini, N., Bonuccelli, U., Fornai, F., & Giorgi, F. S. (2020) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01087-7 · Cited by 47
The dopaminergic system promotes neprilysin-mediated degradation of amyloid-β in the brain
Watamura, N., Kakiya, N., Fujioka, R., Kamano, N., Takahashi, M., Nilsson, P., Saito, T., Iwata, N., Fujisawa, S., & Saido, T. C. (2024) · Science Signaling · doi:10.1126/scisignal.adk1822 · Cited by 44
Cankar, N., Beschörner, N., Tsopanidou, A., Qvist, F. L., Colaço, A. R., Andersen, M., Kjærby, C., Delle, C., Lambert, M., Mundt, F., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114977 · Cited by 45
Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer’s disease
Gentier, R. J. G., & van Leeuwen, F. W. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00047 · Cited by 46
Subsite Awareness in Neuropathology Evaluation of National Toxicology Program (NTP) Studies
Rao, D. B., Little, P. B., & Sills, R. C. (2013) · Toxicologic Pathology · doi:10.1177/0192623313501893 · Cited by 43
Stern, A. L., & Naidoo, N. N. (2015) · SpringerPlus · doi:10.1186/s40064-014-0777-6 · Cited by 44
Iannitelli, A. F., Kelberman, M. A., Lustberg, D. J., Korukonda, A., McCann, K. E., Mulvey, B., Segal, A., Liles, L. C., Sloan, S. A., Dougherty, J. D., et al. (2022) · eNeuro · doi:10.1523/eneuro.0483-22.2022 · Cited by 49
Tolomeo, D., Micotti, E., Serra, S. C., Chappell, M. A., Snellman, A., & Forloni, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-27839-7 · Cited by 43
LUPIEN, S. J., Lord, C., Sindi, S., Wilkinson, C. W., & Fiocco, A. J. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00097-8 · Cited by 42
Kelly, S. C., McKay, E. C., Beck, J. S., Collier, T. J., Dorrance, A. M., & Counts, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190090 · Cited by 44
Pamphlett, R., & Jew, S. K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142445 · Cited by 42
Bouvier, D. S., Fixemer, S., Heurtaux, T., Jeannelle, F., Frauenknecht, K. B. M., & Mittelbronn, M. G. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.814889 · Cited by 43
Plini, E. R. G., O’Hanlon, E., Boyle, R. T., Sibilia, F., Rikhye, G., Kenney, J. P. M., Whelan, R., Melnychuk, M. C., Robertson, I. H., & Dockree, P. M. (2021) · Cells · doi:10.3390/cells10071829 · Cited by 45
Kelberman, M. A., Anderson, C. R., Chlan, E., Rorabaugh, J. M., McCann, K. E., & Weinshenker, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215546 · Cited by 42
MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research
Zimmer, E. R., Parent, M. J., Cuello, A. C., Gauthier, S. G., & Rosa‐Neto, P. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.07.002 · Cited by 41
Voice biomarkers as indicators of cognitive changes in middle and later adulthood
Mahon, E., & Lachman, M. E. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.06.010 · Cited by 39
Morawski, M., Hartlage‐Rübsamen, M., Jäger, C., Waniek, A., Schilling, S., Schwab, C., McGeer, P. L., Arendt, T., Demuth, H., & Roßner, S. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0685-y · Cited by 37
Caligiore, D., Giocondo, F., & Silvetti, M. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.09.007 · Cited by 40
Evans, A. K., Defensor, E. B., & Shamloo, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1030609 · Cited by 40
Polak, P. E., Kalinin, S., Braun, D. J., Sharp, A. J., Lin, S. X., & Feinstein, D. L. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07673.x · Cited by 35
Regulation of microglia by neuromodulators: Modulations in major and minor modes
Albertini, G., Etienne, F., & Roumier, A. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135000 · Cited by 35
Lower Locus Coeruleus MRI intensity in patients with late-life major depression
Guinea-Izquierdo, A., Giménez, M., Martínez‐Zalacaín, I., del Cerro, I., Canal-Noguer, P., Blasco, G., Gascón, J., Reñé, R., Rico, I., Camins, À., et al. (2021) · PeerJ · doi:10.7717/peerj.10828 · Cited by 32
Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype
Lane, R. M., & He, Y. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.005 · Cited by 35
Animal Models of Neurodegenerative Disease: Insights from In vivo Imaging Studies
Strome, E. M., & Doudet, D. J. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0093-4 · Cited by 35
Mercan, D., & Heneka, M. T. (2022) · Biology · doi:10.3390/biology11121822 · Cited by 34
Self-citationVisualization of Altered Hippocampal Connectivity in an Animal Model of Alzheimer’s Disease
Jeon, S. G., Kim, Y. J., Kim, K. A., Mook‐Jung, I., & Moon, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0918-y · Cited by 33
Gutiérrez, I. L., González‐Prieto, M., Caso, J. R., García‐Bueno, B., Leza, J. C., & Madrigal, J. L. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01695-6 · Cited by 35
Havekes, R., Heckman, P. R. A., Wams, E. J., Stasiukonytė, N., Meerlo, P., & Eisel, U. L. M. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109420 · Cited by 35
Rapid eye movement sleep behavior disorder in patients with probable Alzheimer’s disease
Wang, P., Wing, Y. K., Xing, J., Liu, Y. H., Zhou, B., Zhang, Z., Yao, H., Guo, Y., Shang, Y., & Zhang, X. (2015) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0382-8 · Cited by 34
Dual effects of noradrenaline on astroglial production of chemokines and pro-inflammatory mediators
Hinojosa, A. E., Caso, J. R., García‐Bueno, B., Leza, J. C., & Madrigal, J. L. M. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-81 · Cited by 36
Irmler, M., Gentier, R. J. G., Dennissen, F. J. A., Schulz, H., Bolle, I., Hölter, S. M., Kallnik, M., Cheng, J. J., Klingenspor, M., Rozman, J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1003-7 · Cited by 34
The connections of Locus Coeruleus with hypothalamus: potential involvement in Alzheimer’s disease
Giorgi, F. S., Galgani, A., Puglisi‐Allegra, S., Busceti, C. L., & Fornai, F. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02338-8 · Cited by 38
Development of amyloid burden in African Green monkeys
Kalinin, S., Willard, S. L., Shively, C. A., Kaplan, J. R., Register, T. C., Jorgensen, M. J., Polak, P. E., Rubinstein, I., & Feinstein, D. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.023 · Cited by 32
Is Elevated Norepinephrine an Etiological Factor in Some Cases of Alzheimers Disease?
Fitzgerald, P. J. (2010) · Current Alzheimer Research · doi:10.2174/156720510792231775 · Cited by 34
Regulation of MCP‐1 production in brain by stress and noradrenaline‐modulating drugs
Madrigal, J. L. M., García‐Bueno, B., Hinojosa, A. E., Polak, P. E., Feinstein, D. L., & Leza, J. C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06623.x · Cited by 34
Alterations and interactions of subcortical modulatory systems in Alzheimer's disease
Leko, M. B., Hof, P. R., & Šimić, G. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2020.07.016 · Cited by 31
β1‐adrenergic receptor activation enhances memory in Alzheimer's disease model
Coutellier, L. D., Ardestani, P. M., & Shamloo, M. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.57 · Cited by 31
Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2
Takano, A., Varrone, A., Gulyás, B. Z., Karlsson, P., Tauscher, J. T., & Halldin, C. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.05.040 · Cited by 31
Evans, A. K., Park, H. H., Woods, C. E., Lam, R. K., Rijsketic, D. R., Xu, C. L., Chu, E. K., Ciari, P., Blumenfeld, S. E., Vidano, L. M., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03306-1 · Cited by 31
Norepinephrine is a negative regulator of the adult periventricular neural stem cell niche
Weselek, G., Keiner, S., Fauser, M., Wagenführ, L., Müller, J., Kaltschmidt, B., Brandt, M., Gerlach, M., Redecker, C., Hermann, A., et al. (2020) · Stem Cells · doi:10.1002/stem.3232 · Cited by 29
Degenerative alterations in noradrenergic neurons of the locus coeruleus in Alzheimer's disease.
Liu, L., Luo, S., Zeng, L., Wang, W., Yuan, L., & Jian, X. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.24.004 · Cited by 28
Pugh, P. L., Vidgeon-Hart, M., Ashmeade, T. E., Culbert, A. A., Seymour, Z. M., Perren, M. J., Joyce, F., Bate, S. T., Babin, A. L., Virley, D. J., et al. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-8 · Cited by 28
Astrocytic face of Alzheimer's disease
Zorec, R., Parpura, V., Vardjan, N., & Verkhratsky, A. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.021 · Cited by 30
Galgani, A., & Giorgi, F. S. (2023) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-023-01324-9 · Cited by 29
PET Imaging in Animal Models of Alzheimer’s Disease
Chen, B., Marquez-Nostra, B. V., Belitzky, E., Toyonaga, T., Tong, J., Huang, Y. H., & Cai, Z. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.872509 · Cited by 27
Ryan, D., Koss, D. J., Porcu, E., Woodcock, H., Robinson, L., Platt, B., & Riedel, G. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1314-4 · Cited by 27
Mehta, R., Singh, S., Khanday, M. A., & Mallick, B. N. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.016 · Cited by 27
del Cerro, I., Villarreal, M. F., Abulafia, C., Duarte-Abritta, B., Sánchez, S. M., Castro, M. N., Bocaccio, H., Ferrer, I., Menchón, J. M., Sevlever, G. E., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.01.018 · Cited by 26
Neurotransmitter-based strategies for the treatment of cognitive dysfunction in Down syndrome
Das, D., Phillips, C., Hsieh, W., Sumanth, K., Dang, V., & Salehi, A. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.05.004 · Cited by 27
McKay, J. L., Nye, J. A., Goldstein, F. C., Sommerfeld, B., Smith, Y., Weinshenker, D., & Factor, S. A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106048 · Cited by 25
Associations between MRI-assessed locus coeruleus integrity and cortical gray matter microstructure
Elman, J. A., Puckett, O. K., Hagler, D. J., Pearce, R. C., Fennema‐Notestine, C., Hatton, S. N., Lyons, M. J., McEvoy, L. K., Panizzon, M. S., Reas, E. T., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab475 · Cited by 25
Hisaoka‐Nakashima, K., Ohata, K., Yoshimoto, N., Tokuda, S., Yoshii, N., Nakamura, Y., Wang, D., Liu, K., Wake, H., Yoshida, T., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114146 · Cited by 26
Wang, D., Li, J., Yu, L.-P., Wu, M., Sun, L., & Qi, J. (2016) · Journal of Integrative Neuroscience · doi:10.1142/s021963521650014x · Cited by 25
Role of Insulin Metabolism Disturbances in the Development of Alzheimer Disease: Mini Review
Sabayan, B., Foroughinia, F., Mowla, A., & Borhani‐Haghighi, A. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507312623 · Cited by 24
Yoshioka, Y., Negoro, R., Kadoi, H., Motegi, T., Shibagaki, F., Yamamuro, A., Ishimaru, Y., & Maeda, S. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24733 · Cited by 24
Yoshioka, Y., Kadoi, H., Yamamuro, A., Ishimaru, Y., & Maeda, S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.041 · Cited by 25
Daulatzai, M. A. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9643-3 · Cited by 27
Wang, Z., Cao, X., LaBella, A., Zeng, X., Biegon, A. R., Franceschi, D., Petersen, E. W., Clayton, N., Ulaner, G. A., Zhao, W., et al. (2022) · Medical Physics · doi:10.1002/mp.15653 · Cited by 23
Torrente, D., Su, E. J., Schielke, G. P., Warnock, M., Mann, K. M., & Lawrence, D. A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02748-3 · Cited by 21
Huang, H.-J., Chen, S.-L., & Hsieh‐Li, H. M. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00312 · Cited by 21
Fessel, W. J. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517698790 · Cited by 21
Cassel, J., Mathis, C., Majchrzak, M. J., Moreau, P., & Dalrymple‐Alford, J. C. (2008) · Neurodegenerative Diseases · doi:10.1159/000135615 · Cited by 21
Pisani, F., Pisani, V., Arcangeli, F., Harding, A., & Singhrao, S. K. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20116049 · Cited by 21
Kelley, C. M., Perez, S. E., Overk, C., Wynick, D., & Mufson, E. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102097 · Cited by 20
Galgani, A., Bartolini, E., d’Amora, M., Faraguna, U., & Giorgi, F. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065805 · Cited by 21
Oikawa, N., Ogino, K., Masumoto, T., Yamaguchi, H., & Yanagisawa, K. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.005 · Cited by 19
Hassanein, L., Mulvey, B., Blankenship, H. E., Tish, M., Korukonda, A., Liles, L. C., Sharpe, A. L., Paré, J., Villalba, R. M., Chen, X., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.07.530845 · Cited by 19
Ni, R. (2021) · Pharmaceuticals · doi:10.3390/ph14111179 · Cited by 18
Le, L., Feidler, A. M., Rodrı́guez, L., Cealie, M. Y., Plunk, E. C., Li, H., Kara-Pabani, K., Lamantia, C. E., O’Banion, M. K., & Majewska, A. K. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.022 · Cited by 18
Mehta, R., Singh, A., Bókkon, I., & Mallick, B. N. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150414185737 · Cited by 18
Gentier, R. J. G., Verheijen, B. M., Zamboni, M., Stroeken, M. M. A., Hermes, D. J. H. P., Küsters, B., Steinbusch, H. W. M., Hopkins, D. A., & van Leeuwen, F. W. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00026 · Cited by 18
Choudhary, P., Pacholko, A. G., Palaschuk, J., & Bekar, L. K. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0263-x · Cited by 21
Aguilar, L. F., Hall, H., Orciani, C., Foret, M. K., Kovecses, O., Ducatenzeiler, A., & Cuello, A. C. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12835 · Cited by 17
Spinal cord and parkinsonism: Neuromorphological evidences in humans and experimental studies
Vivacqua, G., Casini, A., Vaccaro, R., Salvi, E. P., Pasquali, L., Fornai, F., Yu, S., & D’Este, L. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.03.001 · Cited by 16
Kummer, C., Winkeler, A., Dittmar, C., Bauer, B., Rueger, M. A., Rückriem, B., Heneka, M. T., Vollmar, S., Wienhard, K., Fraefel, C., et al. (2007) · Molecular Imaging · doi:10.2310/7290.2007.00015 · Cited by 17
Self-citationAyabe, T., Fukuda, T., & Ano, Y. (2020) · Biomolecules · doi:10.3390/biom10010131 · Cited by 17
Metadata
- Authors
- Heneka, M. T., Ramanathan, M., Jacobs, A. H., Dumitrescu-Ozimek, L., Bilkei-Gorzo, A., Debeir, T., Sastre, M., Galldiks, N., Zimmer, A., Hoehn, M., Heiss, W.-D., Klockgether, T., & Staufenbiel, M.
- Affiliations
- University of Bonn (DE)
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-02-01
- Volume
- 26
- Issue
- 5
- Pages
- 1343-1354
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6675491
- OpenAlex
- W2118414216
- Cited by
- 305
- References
- 54
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 18 · 2023: 21 · 2022: 23 · 2021: 18 · 2020: 16 · 2019: 16 · 2018: 12 · 2017: 20 · 2016: 9 · 2015: 17 · 2014: 11 · 2013: 17 · 2012: 19
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
- Max Planck Institute for Plasma Physics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB400)
- International Brain Research Organization
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease pathogenesis, glial inflammation, amyloid plaques, neurodegeneration, memory impairment, brain glucose metabolism, acetylcholinesterase activity, paraventricular thalamus, cholinergic hypothesis
- MeSH terms
- Alzheimer Disease, Animals, Astrocytes, Brain, Cognition Disorders, Female, Locus Coeruleus, Mice, Transgenic, Nerve Degeneration, Norepinephrine, Amyloid beta-Protein Precursor, Microglia, Peroxynitrous Acid, Positron-Emission Tomography, Vesicular Acetylcholine Transport Proteins, Mice, Nitric Oxide Synthase Type II, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review